Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease
- PMID: 26154786
- DOI: 10.1056/NEJMoa1411532
Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease
Abstract
Background: Chronic obstructive pulmonary disease (COPD) is thought to result from an accelerated decline in forced expiratory volume in 1 second (FEV1) over time. Yet it is possible that a normal decline in FEV1 could also lead to COPD in persons whose maximally attained FEV1 is less than population norms.
Methods: We stratified participants in three independent cohorts (the Framingham Offspring Cohort, the Copenhagen City Heart Study, and the Lovelace Smokers Cohort) according to lung function (FEV1 ≥80% or <80% of the predicted value) at cohort inception (mean age of patients, approximately 40 years) and the presence or absence of COPD at the last study visit. We then determined the rate of decline in FEV1 over time among the participants according to their FEV1 at cohort inception and COPD status at study end.
Results: Among 657 persons who had an FEV1 of less than 80% of the predicted value before 40 years of age, 174 (26%) had COPD after 22 years of observation, whereas among 2207 persons who had a baseline FEV1 of at least 80% of the predicted value before 40 years of age, 158 (7%) had COPD after 22 years of observation (P<0.001). Approximately half the 332 persons with COPD at the end of the observation period had had a normal FEV1 before 40 years of age and had a rapid decline in FEV1 thereafter, with a mean (±SD) decline of 53±21 ml per year. The remaining half had had a low FEV1 in early adulthood and a subsequent mean decline in FEV1 of 27±18 ml per year (P<0.001), despite similar smoking exposure.
Conclusions: Our study suggests that low FEV1 in early adulthood is important in the genesis of COPD and that accelerated decline in FEV1 is not an obligate feature of COPD. (Funded by an unrestricted grant from GlaxoSmithKline and others.).
Comment in
-
Exploring Different Phenotypes of COPD.N Engl J Med. 2015 Jul 9;373(2):185-6. doi: 10.1056/NEJMe1503888. N Engl J Med. 2015. PMID: 26154792 No abstract available.
-
Lung function trajectories differ in patients with COPD.Lancet Respir Med. 2015 Sep;3(9):675. doi: 10.1016/S2213-2600(15)00329-X. Epub 2015 Aug 23. Lancet Respir Med. 2015. PMID: 26310689 No abstract available.
-
Lung-Function Trajectories and Chronic Obstructive Pulmonary Disease.N Engl J Med. 2015 Oct 15;373(16):1575. doi: 10.1056/NEJMc1510089. N Engl J Med. 2015. PMID: 26465997 No abstract available.
-
Lung-Function Trajectories and Chronic Obstructive Pulmonary Disease.N Engl J Med. 2015 Oct 15;373(16):1574-5. doi: 10.1056/NEJMc1510089. N Engl J Med. 2015. PMID: 26465998 No abstract available.
Similar articles
-
Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.Lancet Respir Med. 2016 Jun;4(6):454-62. doi: 10.1016/S2213-2600(16)00098-9. Epub 2016 Apr 6. Lancet Respir Med. 2016. PMID: 27061878
-
Lung Function Trajectories Leading to Chronic Obstructive Pulmonary Disease as Predictors of Exacerbations and Mortality.Am J Respir Crit Care Med. 2020 Jul 15;202(2):210-218. doi: 10.1164/rccm.201911-2115OC. Am J Respir Crit Care Med. 2020. PMID: 32289231 Free PMC article.
-
The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression.Am J Med. 2006 Oct;119(10 Suppl 1):4-11. doi: 10.1016/j.amjmed.2006.08.002. Am J Med. 2006. PMID: 16996894 Review.
-
FEV1 decline in patients with chronic obstructive pulmonary disease associated with biomass exposure.Am J Respir Crit Care Med. 2014 Nov 1;190(9):996-1002. doi: 10.1164/rccm.201404-0720OC. Am J Respir Crit Care Med. 2014. PMID: 25172140
-
Natural history of COPD: Focusing on change in FEV1.Respirology. 2016 Jan;21(1):34-43. doi: 10.1111/resp.12589. Epub 2015 Jul 15. Respirology. 2016. PMID: 26176980 Review.
Cited by
-
Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohort.Respir Res. 2021 Apr 26;22(1):126. doi: 10.1186/s12931-021-01707-x. Respir Res. 2021. PMID: 33902556 Free PMC article.
-
Data-driven modelling of neurodegenerative disease progression: thinking outside the black box.Nat Rev Neurosci. 2024 Feb;25(2):111-130. doi: 10.1038/s41583-023-00779-6. Epub 2024 Jan 8. Nat Rev Neurosci. 2024. PMID: 38191721 Review.
-
Pulmonary Consequences of Prenatal Inflammatory Exposures: Clinical Perspective and Review of Basic Immunological Mechanisms.Front Immunol. 2020 Jun 19;11:1285. doi: 10.3389/fimmu.2020.01285. eCollection 2020. Front Immunol. 2020. PMID: 32636848 Free PMC article. Review.
-
Characterisation of pulmonary function trajectories: results from a Brazilian cohort.ERJ Open Res. 2020 Aug 25;6(3):00065-2020. doi: 10.1183/23120541.00065-2020. eCollection 2020 Jul. ERJ Open Res. 2020. PMID: 32864380 Free PMC article.
-
Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma.N Engl J Med. 2016 May 12;374(19):1842-1852. doi: 10.1056/NEJMoa1513737. N Engl J Med. 2016. PMID: 27168434 Free PMC article. Clinical Trial.